K. Milde-langosch et al., Expression of cyclin-dependent kinase inhibitors p16(MTS1), p21(WAF1), andp27(KIP1) in HPV-positive and HPV-negative cervical adenocarcinomas, VIRCHOWS AR, 439(1), 2001, pp. 55-61
Citations number
40
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
Inactivation or down-regulation of the cell-cycle inhibitors p16(MTS1), p21
(WAF1), and p27(KIP1) is involved in the carcinogenesis of various human tu
mors. In cervical squamous cell carcinomas that are associated with human p
apillomavirus (HPV) infection, the expression or function of these proteins
is impaired by the action of viral oncoproteins E6 and E7. Comparably less
is known about the role of these cyclin-dependent kinase inhibitors in cer
vical adenocarcinomas, 15-40% of which are HPV negative. Therefore, we stud
ied the expression of p16(MTS1), p21(WAF1), and p27(KIP1) by immunohistoche
mistry in 60 cervical adenocarcinomas. HPV infection was determined by PCR,
and HPV 16 and 18 E6/E7 oncogene expression was analyzed by RNA-RNA in sit
u hybridization. We found significant correlations of strong p16 expression
with HPV 16/18 infection and HPV 16/18 E6/E7 oncogene expression (P=0.001)
. Moderate or strong p16 expression was also observed in 41% of HPV-negativ
e carcinomas, indicating that HPV-independent mechanisms might also lead to
p16 overexpression. In addition, stronger p2l and p27 expression was signi
ficantly associated with the detection of HPV 16 or 18 E6/E7 transcripts (P
=0.015 and 0.030, respectively). Obviously, the tumor suppressor action of
these proteins can be overcome in HPV-positive lesions. In contrast, absent
or low p16, p21, and p27 immunostaining was observed in most HPV-negative
cervical adenocarcinomas and might contribute to carcinogenesis in these tu
mors.